SEC Form 4 · accession 0001209191-18-041182
Kura Oncology, Inc. · KURA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Farnam
Officer — Chief Operating Officer
Period of report
Jul 2, 2018
Accepted (ET)
Jul 3, 2018 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001422143
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase common stockF1 | $18.45 | Jul 2, 2018 | A | 115,000 | A | — | Jul 1, 2028 | Common Stock | 115,000 | 115,000 | D |
Explanation of responses
- F1This option vests as follows: one-fourth on July 1, 2019 and 1/48th each month thereafter for the remaining three years.